Moleculin Biotech, Inc. (MBRX)
6.63
-0.62
(-8.55%)
USD |
NASDAQ |
Dec 09, 16:00
6.46
-0.17
(-2.56%)
After-Hours: 20:00
Moleculin Biotech Shareholders Equity (Quarterly): -26.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Harvard Bioscience, Inc. | 14.07M |
| Intensity Therapeutics, Inc. | 7.222M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.35M |
| Total Liabilities (Quarterly) | 47.27M |
| Debt to Equity Ratio | -0.0145 |
| Current Ratio | 1.388 |
| Net Debt Paydown Yield | 0.11% |